Brief: Aptose Announces Pricing Of $8.4 Million Public Offering And A Concurrent $4 Million Private Placement With Hanmi Pharmaceutical
26/01/2024 13:31
Jan 26 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE ANNOUNCES PRICING OF $8.4 MILLION PUBLIC OFFERING
AND A
CONCURRENT $4 MILLION PRIVATE PLACEMENT WITH HANMI
PHARMACEUTICAL
* APTOSE BIOSCIENCES INC -PRICING OF UNDERWRITTEN PUBLIC
OFFERING
OF 4.9 MILLION COMMON SHARES OF CO AT PUBLIC OFFERING PRICE OF
US $1.71 PER SHARE
* APTOSE BIOSCIENCES INC -UNDER TERMS OF STRATEGIC
INVESTMENT,
HANMI WILL PURCHASE EACH COMMON SHARE AT PRICE OF $1.90
Source text for Eikon: ID:nGNX1qMVCC
Further company coverage: APS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting